Press Releases
Search
-
27 Jul 2017
Sysmex and bioMérieux Agreed to Dissolve the Joint Venture Sysmex bioMérieux Co., Ltd.
Sysmex Corporation (“Sysmex”) and bioMérieux S.A. (“bioMérieux”) (Paris:BIM) announce they have agreed to transfer all of Sysmex’ holdings in Sysmex bioMérieux Co., Ltd. (Tokyo, Japan) to bioMérieux t...
-
20 Jul 2017
Information financière du 2e trimestre 2017
Good sales dynamic confirmed in second-quarter 2017, with sales up 11.3% over the first half at constant exchange rates and scope of consolidation: €1,134 million in sales Up 13.3% as reported Noticea...
-
01 Jun 2017
boMérieux receives FDA Clearance for BioFire's FilmArray® Respiratory Panel 2 (RP2)
The FilmArray® RP2 reduces sample-to-result time to only 45 minutes while enhancing pathogen coverage and overall sensitivity...
-
20 Apr 2017
The FilmArray® Respiratory Panel 2 plus (RP2plus) gets CE marked
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that the FilmArray® Respiratory Panel 2 plus (RP2plus) is CE marked. The FilmArray® RP2plus panel tests for 22 pathogen...
-
20 Apr 2017
bioMérieux – First-Quarter 2017 Business Review
Strong sales dynamic in first-quarter 2017, with sales up 13.7% at constant exchange rates and scope of consolidation: €568 million in sales Up 16.3% as reported Equipment sales up sharply Accelerated...
-
05 Apr 2017
bioMérieux receives FDA 510(k) clearance for its BacT/ALERT® VIRTUO™ fully automated blood culture system
bioMérieux, a major player in the field of in vitro diagnostics, and the world leader in microbiology, announces that BacT/ALERT® VIRTUO™, its fully automated blood culture system, has received 510(k)...
-
01 Mar 2017
bioMérieux – 2016 Financial Results
Remarkable growth in sales in 2016, up 9.6% at constant exchange rates and scope of consolidation: €2,103 million in sales Up 7.1% as reported Contributive operating income before non-recurring items:...
-
01 Mar 2017
bioMérieux – 2016 Financial Results
Remarkable growth in sales in 2016, up 9.6% at constant exchange rates and scope of consolidation: €2,103 million in sales Up 7.1% as reported Contributive operating income before non-recurring items:...
-
24 Feb 2017
bioMérieux’s VIDAS® B•R•A•H•M•S PCT™ becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis
bioMérieux, a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of VIDAS® B•R•A•H•M•S PCT™, an auto...
-
24 Feb 2017
bioMérieux Sells its Hemostasis Line of Business
Marcy l'Etoile - 05/25/2006. bioMérieux, a global leader in the field of in vitro diagnostics, today announced that it has signed an agreement to sell its hemostasis range of products to Trinity Biote...
-
19 Jan 2017
bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury
bioMérieux, a world leader in the field of in vitro diagnostics and Banyan Biomarkers, an innovative biomarkers company developing blood tests capable of diagnosing traumatic brain injuries (TBI), ann...
-
19 Jan 2017
bioMérieux – Information financière du 4e trimestre 2016
Croissance remarquable des ventes en 2016, +9,6 % à taux de change et périmètre constants, alimentée par toutes les régions et par toutes les gammes stratégiques : Chiffre d’affaires : 2 103 millions ...
-
19 Jan 2017
bioMérieux – Fourth-Quarter 2016 Business Review
Remarkable growth in sales in 2016, up 9.6% like-for-like, lifted by all regions and all strategic lines: €2,103 million in sales Up 7.1% as reported Strong contribution from the Americas region to Gr...
-
10 Nov 2016
bioMérieux launches eMAG®, a new generation automated system for the extraction of DNA and RNA
bioMérieux, a world leader in the field of in vitro diagnostics, has announced the launch of eMAG®, its new molecular biology platform for the extraction of nucleic acids (DNA, RNA). eMAG® builds on t...
-
07 Nov 2016
Pierre Boulud appointed Corporate Vice President of the Asia Pacific region at bioMérieux
Marcy l’Étoile, France – November 7, 2016 – bioMérieux, a world leader in the field of in vitro diagnostics, has announced the appointment of Pierre Boulud to the position of Corporate VP in charge of...